SCHEMBL5813776

SCHEMBL5813776

Cc1cccc(-c2nc(N3CCN(C)CC3)sc2-c2ccnc(NC3CC3)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.45
IKBKB O14920 1/20 0.45
BRAF P15056 1/20 0.45
HRH4 Q9H3N8 1/20 0.44
CDK2 P24941 2/20 0.43
CDK4 P11802 2/20 0.43
CCNT1 O60563 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNA2 P20248 1/20 0.43
CCND1 P24385 1/20 0.43
CCND3 P30281 1/20 0.43
CDK7 P50613 1/20 0.43
CDK9 P50750 1/20 0.43
CCNH P51946 1/20 0.43
CDK6 Q00534 1/20 0.43
MAPK10 P53779 1/20 0.41
RIPK2 O43353 1/20 0.41
KCNH2 Q12809 1/20 0.41
RET P07949 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814835 0.92 MAPK14 (0.48) MAPK14IKBKBBRAFCDK2CDK4
SCHEMBL5815238 0.91 MAPK14 (0.45) MAPK14IKBKBBRAFCDK2CDK4
SCHEMBL5818597 0.90 BRAF (0.53) IKBKBBRAFHRH4CDK2CCNA2
SCHEMBL5814087 0.90 KCNH2 (0.49) MAPK14IKBKBBRAFCDK2CDK4
SCHEMBL5819465 0.89 MAPK14 (0.51) MAPK14BRAFHRH4CDK2CDK4
SCHEMBL5818908 0.88 MAPK14 (0.49) MAPK14IKBKBBRAFHRH4CDK2
SCHEMBL5817861 0.88 MAPK14 (0.50) MAPK14BRAFHRH4CDK2CDK4
SCHEMBL5814577 0.87 BRAF (0.50) IKBKBBRAFHRH4CDK2CDK4
SCHEMBL5817136 0.87 KCNH2 (0.49) MAPK14IKBKBBRAFCDK2CDK4
SCHEMBL5815400 0.87 MAPK14 (0.49) MAPK14BRAFHRH4CDK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed